Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $KBEV.C) (OTC: $KBEVF) (CSE: $FONE.C) (OTCQB: $FLOOF) (CSE: $MTEC.C) and (TSXV: $GENE.V) (OTCQX: $IVITF)
Delta, Kelowna, BC - January 17, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $KBEV.C) (OTC: $KBEVF) (CSE: $FONE.C) (OTCQB: $FLOOF) (CSE: $MTEC.C) and (TSXV: $GENE.V) (OTCQX: $IVITF)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF), Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF), Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF) and INVICTUS MD STRATEGIES CORP. (TSXV: GENE) (OTCQX: IVITF).
Koios Beverage Corp. announced that it has received its first purchase order with GNC Holdings, Inc. (GNC), a leading global health and wellness brand with thousands of retail stores across the US and Canada.
It is the largest single order for product that Koios has received in its corporate history.
The order is for Koios's four most popular flavours - Apricot Vanilla, Berry Genius, Peach Mango, and Pear Guava. The beverages will be available for purchase initially in approximately 2,700 GNC retail stores in the US.
Pittsburgh-based GNC has more than 6,400 retail locations throughout the United States and Canada and franchise operations in approximately 50 international markets. GNC Canada is based in Mississauga, Ontario and operates as a subsidiary of GNC.
"The response to our new product lines at a regional level has exceeded our forecasts and expectations," said Koios CEO Chris Miller. "Demand across the US has grown exponentially and our new national roll out with GNC will allow us to serve our ever-growing consumer base."
Flower One Holdings Inc. today announced a new licensing agreement and Brand Partnership for cannabis-product fulfillment in Nevada. Flower One is licensed to manufacture, distribute and sell the two signature cannabis products from Flyte Concentrates (Flyte™) to all 130 cannabis retailers in Nevada, marking the consumer brand's U.S. market entry following successful launches in other markets.
"This is another milestone partnership for Flower One," said Ken Villazor, Flower One's President and CEO. "Adding Flyte to Flower One's portfolio of Brand Partners further diversifies the line of products we have to offer our retail partners. Flower One is excited to expedite the market entry of Flyte's distillate and edible product lines in Nevada, which hosts more than 55 million tourists annually from all over the world, and is one of the most lucrative cannabis markets in the United States."
As a distillate brand, Flyte is best known for its two product lines: FlytePen and JetPack. FlytePen is a slim distillate vaporizer system with a cartridge containing 0.8ml of premium cannabis oil. Using a proprietary process and formulation, the FlytePen can rapidly vaporize the thickest and most purified cannabis oils. Flyte JetPacks are convenient single-dose 10ml liquid THC or CBD shots, about 2mm thick and about the size of a credit card. The contents of the package can be added to any hot or cold beverage for a discreet experience.
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, and Advica Health, an innovative healthcare navigation service allowing members to access an independent appraisal of their health needs and circumstances, announced the signing of a definitive contract whereby Cannvas.Me will be the exclusive provider of cannabis education and information to the Advica Health community.
"Advica Health is at the forefront of delivering medical treatment efficiently on a membership basis and we are very pleased to become their exclusive provider of physician-backed cannabis education," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "The need to educate Canadians about cannabis and its potential health benefits has never been greater and Cannvas.Me is an ideal learning tool for patients looking to take better control of their own health and wellness through organizations like Advica Health who have their patient's best interests at heart. We believe that with a dedicated cannabis education section on the Advica portal where patients and health care professionals will be able to access evidence-based education and information about cannabis, Advica members will be better positioned to make informed decisions about their health treatments."
Advica Health offers members access to the best facilities at home or abroad and assists in obtaining advice, treatment options and solutions to current health care situations in the most efficient manner possible. Each case is approached on an individual and personalized basis to help navigate the healthcare system and collaboratively create an effective health plan with ongoing care management and support from nurse navigators. Advica is constantly bringing innovative healthcare solutions to its membership with a strong focus on preventative health and wellness, and helps members focus on healthy living to positively impact their overall productivity and quality of life.
INVICTUS MD STRATEGIES CORP. announced that it has submitted its application to list its common shares on the NASDAQ Capital Market. In advance of listing on NASDAQ, the Company will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's Shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements, including the effectiveness of the Form 40-F Registration Statement.
Subject to approval for listing, it is anticipated that the Company's Shares, including the existing Shares trading on the OTCQX under the ticker symbol "IVITF", will trade on NASDAQ under the ticker symbol "INV". The Company's Shares will continue to trade on the TSXV under the ticker symbol "GENE" and on the Frankfurt Stock Exchange under the ticker symbol "8IS1". A trading date will be made public once all regulatory formalities are satisfied.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment